These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31267304)

  • 21. Primary Spontaneous Pneumothorax Admitted in Emergency Unit: Does First Episode Differ from Recurrence? A Cross-Sectional Study.
    Kepka S; Dalphin JC; Parmentier AL; Pretalli JB; Gantelet M; Bernard N; Mauny F; Desmettre T
    Can Respir J; 2017; 2017():2729548. PubMed ID: 28465661
    [No Abstract]   [Full Text] [Related]  

  • 22. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
    Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: Grade 3, requiring assistance for eating, excretion or ambulation).
    WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 18 STUDY GROUP
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Oct; 18(sup1):40-48. PubMed ID: 28872915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Creatine for amyotrophic lateral sclerosis/motor neuron disease.
    Pastula DM; Moore DH; Bedlack RS
    Cochrane Database Syst Rev; 2010 Jun; (6):CD005225. PubMed ID: 20556761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis.
    Rooney J; Burke T; Vajda A; Heverin M; Hardiman O
    J Neurol Neurosurg Psychiatry; 2017 May; 88(5):381-385. PubMed ID: 27888187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis.
    Mandrioli J; Ferri L; Fasano A; Zucchi E; Fini N; Moglia C; Lunetta C; Marinou K; Ticozzi N; Drago Ferrante G; Scialo C; Sorarù G; Trojsi F; Conte A; Falzone YM; Tortelli R; Russo M; Sansone VA; Mora G; Silani V; Volanti P; Caponnetto C; Querin G; Monsurrò MR; Sabatelli M; Chiò A; Riva N; Logroscino G; Messina S; Calvo A
    Eur J Neurol; 2018 Jun; 25(6):861-868. PubMed ID: 29512869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contralateral recurrence of primary spontaneous pneumothorax.
    Huang TW; Lee SC; Cheng YL; Tzao C; Hsu HH; Chang H; Chen JC
    Chest; 2007 Oct; 132(4):1146-50. PubMed ID: 17550937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group.
    Diekmann K; Kuzma-Kozakiewicz M; Piotrkiewicz M; Gromicho M; Grosskreutz J; Andersen PM; de Carvalho M; Uysal H; Osmanovic A; Schreiber-Katz O; Petri S; Körner S
    J Neurol; 2020 Jul; 267(7):2130-2141. PubMed ID: 32266542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical history of chemotherapy or immunosuppressive drug treatment and risk of amyotrophic lateral sclerosis (ALS).
    Kuczmarski T; Stommel EW; Riley K; Tandan R; Chaudhry V; Clawson L; Caller TA; Henegan PL; Facciponte DN; Bradley WG; Andrew AS
    J Neurol; 2017 Aug; 264(8):1763-1767. PubMed ID: 28711998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of a telephone survey system for patients with amyotrophic lateral sclerosis using the ALSFRS-R (Japanese version) and application of this system in a longitudinal multicenter study].
    Atsuta N; Watanabe H; Ito M; Nakamura R; Senda J; Kato S; Sobue G
    Brain Nerve; 2011 May; 63(5):491-6. PubMed ID: 21515929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Six-Minute Walk Test as a Measure of Walking Capacity in Ambulatory Individuals With Amyotrophic Lateral Sclerosis.
    Sanjak M; Langford V; Holsten S; Rozario N; Patterson CGM; Bravver E; Bockenek WL; Brooks BR
    Arch Phys Med Rehabil; 2017 Nov; 98(11):2301-2307. PubMed ID: 28465220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
    Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
    No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy.
    Mandrioli J; Biguzzi S; Guidi C; Sette E; Terlizzi E; Ravasio A; Casmiro M; Salvi F; Liguori R; Rizzi R; Pietrini V; Borghi A; Rinaldi R; Fini N; Chierici E; Santangelo M; Granieri E; Mussuto V; De Pasqua S; Georgoulopoulou E; Fasano A; ; Ferro S; D'Alessandro R
    Neurol Sci; 2015 Dec; 36(12):2243-52. PubMed ID: 26205535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary intake of fruits and beta-carotene is negatively associated with amyotrophic lateral sclerosis risk in Koreans: a case-control study.
    Jin Y; Oh K; Oh SI; Baek H; Kim SH; Park Y
    Nutr Neurosci; 2014 Apr; 17(3):104-8. PubMed ID: 23710627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort.
    Trojsi F; Siciliano M; Femiano C; Santangelo G; Lunetta C; Calvo A; Moglia C; Marinou K; Ticozzi N; Drago Ferrante G; Scialò C; Sorarù G; Conte A; Falzone YM; Tortelli R; Russo M; Sansone VA; Chiò A; Mora G; Poletti B; Volanti P; Caponnetto C; Querin G; Sabatelli M; Riva N; Logroscino G; Messina S; Fasano A; Monsurrò MR; Tedeschi G; Mandrioli J
    J Neurol; 2017 Nov; 264(11):2224-2231. PubMed ID: 28914354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous bilateral primary spontaneous pneumothorax.
    Lee SC; Cheng YL; Huang CW; Tzao C; Hsu HH; Chang H
    Respirology; 2008 Jan; 13(1):145-8. PubMed ID: 18197926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation.
    Lo Coco D; Marchese S; La Bella V; Piccoli T; Lo Coco A
    Chest; 2007 Jul; 132(1):64-9. PubMed ID: 17475635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS).
    Qureshi MM; Hayden D; Urbinelli L; Ferrante K; Newhall K; Myers D; Hilgenberg S; Smart R; Brown RH; Cudkowicz ME
    Amyotroph Lateral Scler; 2006 Sep; 7(3):173-82. PubMed ID: 16963407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between depression and survival in Chinese amyotrophic lateral sclerosis patients.
    Wei Q; Zheng Z; Guo X; Ou R; Chen X; Huang R; Yang J; Shang H
    Neurol Sci; 2016 Apr; 37(4):557-63. PubMed ID: 26758858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study.
    de Jong SW; Huisman MH; Sutedja NA; van der Kooi AJ; de Visser M; Schelhaas HJ; Fischer K; Veldink JH; van den Berg LH
    Am J Epidemiol; 2012 Aug; 176(3):233-9. PubMed ID: 22791740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.